Kainova Therapeutics has dosed the first patient in Europe in [...]

FoRx Therapeutics presents preclinical data on FORX-428, a PARG inhibitor [...]

Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]

AC Immune has initiated a Phase 1 trial of its [...]

Affibody has reported positive Phase 1 data from its licensee [...]

ViiV Healthcare will present new data from its long-acting and [...]

Oncoinvent will present final 24-month follow-up data from its Phase [...]

PulseSight Therapeutics has completed dosing in its Phase 1 clinical [...]

CERo Therapeutics has reported early clinical findings from its ongoing [...]

Orano Med has advanced its long-running collaboration with Roche as [...]